Home » Spine Wave Expanding European Clinical Trials of NuCore IDN
Spine Wave Expanding European Clinical Trials of NuCore IDN
Protein Polymer Technologies (PPTI) announced that its licensee, Spine Wave, has notified PPTI of its intent to expand European human clinical testing of NuCore Injectable Disc Nucleus (IDN), an injectable protein polymer formulation for repair of spinal discs damaged as a result of injury or aging. PPTI manufactures NuCore for Spine Wave's clinical trials.
Yahoo News (http://biz.yahoo.com/prnews/050310/lath019_2.html)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct